top of page
The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) October 11–14, 2026 

Speakers

Ph.D.

Leiden University Medical Center

Annemieke

Aartsma

Ph.D.

Denali Therapeutics

Firoz

Antia

DVM, Dipl.ACVIM

Angelman Syndrome

Allyson

Berent

Ph.D.

University of Oxford

Tom

Brown

Ph.D.

*Keynote Speaker

Thomas R.

Cech

Ph.D.

Massachusetts Institute of Technology

Vikash P.

Chauhan

Ph.D.

Biogen

Brendon E.

Cook

Ph.D.

QurAlis

Hagen

Cramer

Ph.D.

Cornelius Vanderbilt University

Craig

Duvall

Ph.D.

Vanderbilt University

Martin

Egli

Ph.D.

University of California, San Francisco

Justin

Eyquem

Ph.D.

UMass Chan Medical School

Hassan H.

Fakih

Ph.D.

FTS Pharma Consulting

Kevin

Fettes

Ph.D.

Biogen

Steve

Garafalo

Ph.D.

Novartis

Malgorzata

Gonciarz

Ph.D.

Wyss Institute at Harvard

James

Gorman

Ph.D.

AmGen

Lianxiu

Guan

Ph.D.

Contera Pharma

Peter

Hagedorn

Ph.D.

Comanche Biopharma

Vignesh

Narayan Hariharan

Ph.D.

Kumamoto University

Yousuke

Katsuda

US Pharmacopeia

Sarita

Kattel

Ph.D.

Avidity Biosciences

Art

Levin

Ph.D.

Hongene

Xiaocen (Chris)

Li

Ph.D.

Ghent University

Annemieke

Madder

Ph.D.

UCSD

Prashant

Mali

Ph.D.

Providence Therapeutics

Natalia

Martin-Orozco

Ph.D.

McGill University

Maureen

McKeague

Ph.D.

Leal Therapeutics

Eduardo

Paredes

Ph.D.

BioSpring

Timo

Pöstges-Janotta

Ph.D.

Roche

Felix

Schumacher

Ph.D.

GNMmeds LLC

Laura

Sepp-Lorenzino

Ph.D.

BfArM

René

Thürmer

Saskatchewan Workers' Compensation Board

Paula

Trefiak

Ph.D.

BaseCure Therapeutics

Jing

Yang

Ph.D.

UCSD

Gene

Yeo

Ph.D.

Stoke Therapeutics

MEENA

bottom of page